Health Care & Life Sciences » Biotechnology | Array BioPharma Inc.

Array BioPharma Inc.

Array BioPharma Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
211.67 M
Public Float
146.57 M
Array BioPharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.59
Market Cap
$10.46 B
Shares Outstanding
223.1 M
Public Float
216.9 M

Profile

Address
3200 Walnut Street
Boulder Colorado 80301
United States
Employees -
Website http://www.arraybiopharma.com
Updated 07/08/2019
Array BioPharma, Inc. engages in the research, development, and commercialization of targeted small molecule drugs for the treatment of cancer and other high-burden diseases. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony Piscopio, K.

Financials

View All

Ron Squarer
Chief Executive Officer & Director
Kyle A. Lefkoff
Independent Director